Concepedia

Author

Muhammed Shiraz Moosa

University of Cape TownORCID

Also Known As

M S Moosa, Moosa, Muhammed Shiraz, Muhammed S Moosa, Muhammed S. Moosa, Muhammed Shiraz Moosa, Shiraz Moosa

16

Publications

177

Citations

6

H-Index

0

Concepts

All Affiliations

University of Cape TownSomerset HospitalWellcome Centre for Infectious Diseases Research in AfricaImperial College LondonThe Francis Crick Institute
MS

About

Muhammed Shiraz Moosa is an author at University of Cape Town.

Muhammed Shiraz Moosa

×

5

Publications

145

Citations

5

H-Index

YearCitations

A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug–Induced Liver Injury

Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter,

Clinical Infectious Diseases

2020

48

Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial

Sean Wasserman, Angharad Davis, Cari Stek,

Antimicrobial Agents and Chemotherapy

2021

37

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial

Angharad Davis, Sean Wasserman, Cari Stek,

Clinical Infectious Diseases

2022

37

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

Angharad Davis, Sean Wasserman, Mpumi Maxebengula,

Wellcome Open Research

2021

12

Analysis of serum microRNA‐122 in a randomized controlled trial of N‐acetylcysteine for treatment of antituberculosis drug‐induced liver injury

Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R. Dorfman,

British Journal of Clinical Pharmacology

2023

11

Page 1